Fintel reports that on December 2, 2025, Morgan Stanley maintained coverage of Tempus AI (NasdaqGS:TEM) with a Overweight recommendation. Analyst Price Forecast Suggests 24.42% Upside As of November ...

Abstract: Recent advances in transient electromagnetic (TEM) instrument development now allow the study of long-term dynamics in groundwater systems using semi-permanently deployed instrumentation, ...

Three new Charlotte City Council members took the oath of office Monday and promptly voted on a new mayor pro tem as their first order of business. The city welcomed Joi Mayo from west Charlotte’s ...

The latest price target for Tempus AI (NASDAQ:TEM) was reported by Canaccord Genuity on December 22, 2025. The analyst firm set a price target for $80.00 expecting TEM to rise to within 12 months (a ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Monday morning after the company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD ...

Matthew Allard is a multi-award-winning, ACS accredited freelance Director of Photography with over 35 years' of experience working in more than 50 countries around the world. He is the Editor of ...

At IBC 2025 in Amsterdam, Autoscript was showing its new PTZ prompter mounting system. The Autoscript PTZ prompter mounting system is a professional solution for teleprompting with PTZ cameras. The ...

Tempus AI is an innovative healthcare AI company with strong data integration and a positive flywheel effect across its business lines. The Paige acquisition enhances TEM’s digital pathology ...

Autoscript and Autocue have jointly announced the launch of new PTZ prompter solutions. Designed to provide prompting in dynamic multi-camera broadcast environments, the Autoscript PTZ Prompter and ...

BURY ST. EDMUNDS, England—Autoscript and Autocue will showcase their newly launched PTZ prompter system during IBC2025, Sept. 12-15 at the RAI Amsterdam Convention Center. Designed to provide seamless ...

CANADA - 2025/04/23: In this photo illustration, the Tempus AI logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) AstraZeneca ...